These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17998371)

  • 1. Vasopressor support in septic shock.
    Hollenberg SM
    Chest; 2007 Nov; 132(5):1678-87. PubMed ID: 17998371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotrope and vasopressor therapy of septic shock.
    Hollenberg SM
    Crit Care Nurs Clin North Am; 2011 Mar; 23(1):127-48. PubMed ID: 21316572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotrope and vasopressor therapy of septic shock.
    Hollenberg SM
    Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive drugs in circulatory shock.
    Hollenberg SM
    Am J Respir Crit Care Med; 2011 Apr; 183(7):847-55. PubMed ID: 21097695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic support in septic shock: a critical review.
    Póvoa P; Carneiro AH
    Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum treatment of vasopressor-dependent distributive shock.
    Vincent JL; Leone M
    Expert Rev Anti Infect Ther; 2017 Jan; 15(1):5-10. PubMed ID: 27774825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.
    Hollenberg SM; Ahrens TS; Annane D; Astiz ME; Chalfin DB; Dasta JF; Heard SO; Martin C; Napolitano LM; Susla GM; Totaro R; Vincent JL; Zanotti-Cavazzoni S
    Crit Care Med; 2004 Sep; 32(9):1928-48. PubMed ID: 15343024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions for sepsis and septic shock research.
    Sharawy N; Lehmann C
    J Surg Res; 2015 Apr; 194(2):520-527. PubMed ID: 25596653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock.
    Qiu X; Huang Y; Xu J; Qiu H; Yang Y
    J Surg Res; 2014 May; 188(2):503-9. PubMed ID: 24582066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic management of septic shock.
    Lipcsey M; Castegren M; Bellomo R
    Minerva Anestesiol; 2015 Nov; 81(11):1262-72. PubMed ID: 25369134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECMO with vasopressor use during early endotoxic shock: Can it improve circulatory support and regional microcirculatory blood flow?
    Mu TS; Becker AM; Clark AJ; Batts SG; Murata LM; Uyehara CFT
    PLoS One; 2019; 14(10):e0223604. PubMed ID: 31600278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic optimization of sepsis-induced tissue hypoperfusion.
    Zanotti Cavazzoni SL; Dellinger RP
    Crit Care; 2006; 10 Suppl 3(Suppl 3):S2. PubMed ID: 17164014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
    Morelli A; Ertmer C; Pietropaoli P; Westphal M
    Expert Opin Pharmacother; 2009 Oct; 10(15):2569-75. PubMed ID: 19735216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and oxygen transport monitoring to titrate therapy in septic shock.
    Shoemaker WC; Appel PL; Kram HB; Bishop M; Abraham E
    New Horiz; 1993 Feb; 1(1):145-59. PubMed ID: 7922388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2 agonists to reduce vasopressor requirements in septic shock?
    Pichot C; Géloën A; Ghignone M; Quintin L
    Med Hypotheses; 2010 Dec; 75(6):652-6. PubMed ID: 20817367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.